Open AccessThree Years of Progress Toward Achieving Hepatitis C Elimination in the Country of Georgia, April 2015–March 2018
Author(s) -
Tengiz Tsertsvadze,
Amiran Gamkrelidze,
Nikoloz Chkhartishvili,
Akaki Abutidze,
Lali Sharvadze,
Vakhtang Kerashvili,
Maia Butsashvili,
David Metreveli,
Lia Gvinjilia,
Shaun Shadaker,
Muazzam Nasrullah,
Ekaterine Adamia,
Stefan Zeuzem,
Nezam H. Afdhal,
Sanjeev Arora,
Karla Thornton,
Beth Skaggs,
Tinatin Kuchuloria,
Maia Lagvilava,
David Sergeenko,
Francisco Averhoff
Publication year - 2019
Publication title -
clinical infectious diseases/clinical infectious diseases (online. university of chicago. press)
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/ciz956
Subject(s) - medicine , sofosbuvir , hepatitis c , ledipasvir , hepatitis c virus , disease control , family medicine , pediatrics , immunology , virology , virus , ribavirin
In April 2015, in collaboration with the US Centers for Disease Control and Prevention and Gilead Sciences, the country of Georgia embarked on the world's first hepatitis C elimination program. We aimed to assess progress toward elimination targets 3 years after the start of the elimination program.